Effect of Data Quality and Data Quantity on the Estimation of Intrinsic Solubility: Analysis Based on a Single-Source Data Set

Effect of Data Quality and Data Quantity on the Estimation of Intrinsic Solubility: Analysis Based on a Single-Source Data Set

Publication: Mol Pharm
Software: ADMET Predictor®
Division: Cheminformatics

Aqueous solubility is one of the most important physicochemical properties of drug molecules and a major driving force for oral drug absorption.

Phase I Clinical Trial of NH130 and the Prediction of its Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling

Phase I Clinical Trial of NH130 and the Prediction of its Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling

Authors: Zhang K, Zhao S, Du J, Zhang L
Publication: Front Pharmacol
Software: GastroPlus®
Division: PBPK

Parkinson’s disease psychosis (PDP) is a common and distressing complication of Parkinson’s disease (PD), characterized by hallucinations and delusions.

AI for Pharmacological Modeling

AI for Pharmacological Modeling

Authors: Lu J, Sun T

Pharmacological modeling plays a key role in drug development by guiding decisions on dosing to optimize safety and efficacy and ultimately streamlining the path to successful therapeutic interventions.

CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide

CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide

Publication: Intl J Pharm
Software: GastroPlus®
Division: PBPK

The objectives of this study were to expand and implement a Computational Fluid Dynamics (CFD)-Dissolution, Absorption and Clearance (DAC)-Pharmacokinetics (PK) multi-physics modeling framework for simulating the transport of suspension-based nasal corticosteroid sprays.

Application of Virtual Drug Study to New Drug Research and Development: Challenges and Opportunity

Application of Virtual Drug Study to New Drug Research and Development: Challenges and Opportunity

Authors: Li X, Liu S, Liu D, Yu M, Wu X, Wang H
Publication: Clin Pharmacokinet
Software: GastroPlus®
Division: PBPK

In recent years, virtual drug study, as an emerging research strategy, has become increasingly important in guiding and promoting new drug research and development.

PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management

PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management

Publication: Pharmaceutics
Software: GastroPlus®
Division: PBPK

This study aimed to model the pharmacokinetics of lamotrigine (LTG) and efavirenz (EFV) in pregnant women using physiologically based pharmacokinetic (PBPK) and pregnancy-specific PBPK (p-PBPK) models.

Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modeling

Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modeling

Publication: CPT Pharmacometrics Syst Pharmacol
Software: GastroPlus®
Division: PBPK

Omaveloxolone is a nuclear factor (erythroid-derived 2)-like 2 activator approved in the United States and the European Union for the treatment of patients with Friedreich ataxia aged ≥16 years, with a recommended dosage of 150 mg orally once daily on an empty stomach.